Is ACA a buy according to AI stock analysis?

ACA AI stock analysis does not label Arcosa as a straightforward buy because the stock is now a merger play. CRH has agreed to pay $150.00 per share in cash, about 3.3% above the July 31 close of $145.20, so the remaining return depends on deal completion, and the risk is that a failed deal reverts the stock toward its pre-deal range.

What is the ACA AI stock forecast?

The ACA AI stock forecast is anchored to the CRH $150 per share cash offer. Around the $145.20 cutoff price, the bullish scenario is roughly $150 to $160, the base scenario is roughly $148 to $152, and the bearish scenario is roughly $110 to $135 if the deal fails, depending on approvals, competing bids, and closing timing.

What technical levels matter for ACA?

The key ACA technical levels are the $146.92 52-week high and the $150 offer price as resistance, the $143 to $144 near-support zone, the $136.94 50-day moving average, and the $117.24 200-day moving average. RSI was around 66 at the cutoff, elevated but not deeply overbought.

Can AI predict ACA stock price?

No, AI cannot reliably predict stock prices. AI can organize the deal terms, filings, financials, market cap math, technical levels, and scenario analysis, but ACA can still move sharply on the shareholder vote, antitrust review, merger litigation, a competing bid, or a deal termination.

How should I use this ACA AI trading strategy?

Use this ACA AI trading strategy as a research checklist, not a personal instruction. Confirm the live price, the merger spread, the shareholder vote date, regulatory milestones, position size, stop level, and portfolio risk before making any trade.

What happens if the CRH acquisition of Arcosa closes?

If the CRH acquisition closes, Arcosa shareholders receive $150.00 per share in cash and Arcosa is expected to operate as a wholly owned subsidiary of CRH. The deal remains subject to Arcosa shareholder approval and regulatory and antitrust review as of the August 3, 2026 data cutoff.

What happens if the CRH deal fails?

If the CRH deal fails, ACA would likely revert toward its pre-deal trading range, roughly the $110 to $135 zone around the 50-day and 200-day moving averages, and the stock would again be valued on its standalone infrastructure earnings and cyclical exposure rather than the $150 offer.

Arcosa Inc. research snapshot

ACA AI Stock Analysis

ACA AI stock analysis currently reads Arcosa Inc. through a merger lens. On June 22, 2026, CRH agreed to acquire Arcosa for $150.00 per share in an all-cash transaction valued at about $8.5 billion including debt, subject to Arcosa shareholder and regulatory approval. The analysis is not a certain price prediction. At the August 3, 2026 cutoff, the latest verified close used here was $145.20 on July 31, 2026, market capitalization was about $7.13 billion, and the stock traded about 3.3% below the $150 offer, which is a narrow merger spread reflecting high but not certain completion odds. The main question is now deal timing and closing risk, not a standalone growth forecast. This is informational research and not investment advice.

Current price

$145.20

Market cap

$7.13 billion

AI score

70 / 100

Rating

Acquisition target: CRH $150 cash offer, completion driven

Trend status

Consolidating near 52-week high, about 3% below the cash offer

Data cutoff (updated monthly)

August 4, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness: B-level information richness. Arcosa is a well-covered mid-cap industrial with SEC filings, a signed merger agreement, analyst commentary, and segment data, but the final outcome depends on shareholder and regulatory decisions that cannot be predicted from filings alone.
bias Check: The main AI bias risk is anchoring on the $150 cash offer and ignoring the deal-break scenario, or treating the narrow spread as proof of closing. This page separates filing-backed deal terms and financial data from scenario judgments and explicitly prices in a failure path.
ai Confidence: Medium-high data confidence
investment Certainty: Medium. The acquisition sets a clear cash anchor at $150 per share, but the stock still carries completion risk from the shareholder vote, antitrust review, and timing, so certainty is moderate rather than high.

Quick verdict table

Dimension	Conclusion	Confidence
Business quality	Arcosa sells infrastructure products and services across construction materials, engineered structures (wind towers, utility structures), and transportation (inland barges), with recurring revenue from aggregates and project-driven revenue from wind towers and barges.	High
Moat	The moat is moderate, driven by local aggregates quarries (transportation cost barrier), scale in wind tower manufacturing, and long-standing customer relationships in barges. Pricing power varies by segment.	Medium
Management	Management built Arcosa through acquisition-led growth and margin expansion since the 2018 spin-off from Trinity Industries, and in 2026 it agreed to sell the company to CRH at $150 per share, a premium to the pre-deal market price.	Medium-high
Financial trend	TTM revenue was about $2.82 billion and TTM net income was about $222.6 million. FY2025 revenue rose 12.2% to $2.88 billion and net income rose 122.7% to $208.4 million. Q1 2026 saw seasonal weakness with $571.7 million revenue and $37.8 million net income.	High
Valuation	The $150 cash offer is about 3.3% above the July 31 close and roughly 35x trailing EPS, while the market price sits near 32x TTM earnings. On a standalone basis the multiple is rich; the deal price now anchors the analysis.	Medium
Technical trend	ACA is in a bullish trend above its 50-day and 200-day moving averages and near its 52-week high of $146.92, with RSI around 66. Price is effectively capped just below the $150 offer in the absence of a higher bid.	Medium-high
Risk level	The dominant risk is deal completion: shareholder approval, antitrust and regulatory review, and merger litigation. If the deal fails, standalone risks return, including cyclical wind energy demand, barge demand, and interest-rate sensitivity.	Medium-high
AI confidence	High confidence for the deal terms, market cap math, financials, technical levels, and analyst reactions. Lower confidence for the exact closing date and for whether a competing bid emerges.	High data confidence
Investment certainty	Medium certainty. The cash offer provides a clear valuation anchor, but completion risk keeps certainty below high, and a failed deal would likely revert the stock toward its pre-deal range.	Medium

ACA AI stock forecast

ACA AI Stock Forecast Scenarios

The ACA AI stock forecast is anchored to the CRH $150.00 per share all-cash offer. It does not claim that AI can predict a specific future price. The bullish case requires the deal to close at $150 or a competing bidder to top it. The base case assumes the deal closes at $150 on schedule with a normal merger spread. The bearish case assumes the deal breaks and the stock reverts toward pre-deal levels.

Bullish case

$150 to $160

More likely if the CRH deal closes at $150 or a competing bidder emerges above $150, shareholder approval is smooth, regulatory review clears without conditions, and any litigation resolves quickly.

Base case

$148 to $152

More likely if the deal closes at $150 per share on the expected timetable and the stock converges toward the offer price as the closing date approaches, keeping a small spread for timing risk.

Bearish case

$110 to $135

More likely if the deal fails on a shareholder vote, antitrust objection, or regulatory challenge, or if timing slips materially. The stock would then revert toward its pre-deal trading range near the 50-day and 200-day moving averages.

ACA AI technical analysis

ACA AI Technical Analysis

ACA AI technical analysis starts from the $145.20 July 31, 2026 close used for this August 3, 2026 static page. Chart data showed a bullish trend with price above rising moving averages, near the 52-week high, and held just under the $150 cash offer. RSI was around 66 and volume was below average. Because this page does not fetch request-time market data, traders should confirm levels on a live chart before acting.

Level	Value	Why it matters
Current price	$145.20	Latest verified close used for this page as of the July 31, 2026 trading day.
Offer price	$150.00	CRH all-cash offer per share. Acts as a natural resistance ceiling unless a higher bid appears.
Near resistance	$146.92	The 52-week high. ACA has been consolidating just below this level and below the $150 offer.
Near support	$143 to $144	The recent 20-day low zone and lower Bollinger band area near $144.61.
50-day moving average	About $136.94	Chart data showed ACA well above the 50-day moving average. A close below it would signal momentum loss.
200-day moving average	About $117.24	The long-term trend anchor. A break below it in a failed-deal scenario would point to a full reversion.
Momentum	RSI about 66, elevated	RSI was elevated but not deeply overbought, consistent with a stock capped near a cash offer.
MACD	MACD +1.94, signal +2.57	The MACD line was slightly below its signal line, showing short-term momentum cooling while the trend stays intact.
Volume	About 599,500 shares, below average	Volume on the cutoff day was below the 20-day average of about 738,600 shares, typical ahead of a deal milestone.
Volatility	ATR about $1.16, roughly 0.8%	Volatility is low and compressed relative to the year, reflecting the merger-spread setup.
Invalidation	Close below $137, then $117	A close below the 50-day area weakens near-term momentum. A break below the 200-day area would challenge the long uptrend.

ACA AI trading strategy

ACA AI Trading Strategy Framework

The ACA AI trading strategy is a rules-based framework, not personalized advice. Because Arcosa is under a signed $150 cash acquisition, the relevant setup is merger-arbitrage focused on the deal spread and closing milestones, with clear invalidation levels if the transaction fails.

Merger-spread setup

Assess the spread between the market price and the $150 offer, then monitor deal milestones: the Q2 2026 earnings on August 5, the shareholder vote date, antitrust review progress, and merger litigation. The spread narrows as the closing date approaches.

Define the worst case if the deal fails, which is a reversion toward the pre-deal range near the 50-day and 200-day moving averages. Size the position so a failed deal stays inside your risk tolerance.

Mean-reversion setup

If the spread widens on deal headlines, do not assume it will close. Instead verify the specific cause, such as a regulatory delay or a voting concern, before treating the wider spread as an opportunity.

Do not average down solely because the price sits below the offer. Check the reason for the wider spread first and confirm the thesis is intact.

Fundamental monitor

Track Arcosa Q2 2026 results on August 5, 2026, the shareholder meeting and vote, CRH commentary on expected closing, antitrust and regulatory updates, and any competing bid or termination event.

Lower the rating if the shareholder vote fails, regulators object, or the merger agreement is terminated, since those would reset the valuation to a standalone basis.

Investment research summary

Four-master Research Compression

Business essence

Arcosa produces infrastructure products for construction (aggregates, asphalt), energy (wind towers, utility structures), and transportation (inland barges, marine components), serving government, utility, and industrial customers across the United States.

Moat

Moderate moat comes from local aggregates quarry positions protected by transport costs, manufacturing scale in wind towers, and customer relationships in barges. Pricing power is strongest in construction materials and weakest in energy equipment.

Munger risk inversion

The thesis fails most directly if the CRH deal breaks on a shareholder vote, antitrust review, or regulatory challenge, pushing the stock back toward pre-deal levels. Standalone failure paths include slower infrastructure spending, wind energy tax credit changes, cyclical barge demand, and overpaying acquisitions.

Management

Since the 2018 Trinity spin-off, management grew Arcosa through acquisitions, expanded margins, and maintained a solid balance sheet. In 2026 it agreed to sell the company to CRH at $150 per share, locking in a premium to the pre-deal price.

Industry trend

Arcosa benefits from long-term tailwinds in U.S. infrastructure spending, renewable energy buildout, and domestic manufacturing, which is why CRH, a large building materials and data center hungry provider, sought the business. Wind towers and barges remain cyclical and project-driven.

Valuation and margin of safety

The $150 cash offer is about 3.3% above the July 31 close and roughly 35x trailing EPS, leaving a thin margin of safety on the spread itself. The main protection is the signed agreement and CRH financing, while the main risk is that the deal does not complete.

Source-backed data

ACA Data Table

Every metric below includes a source and last verification date.

Metric	Value	Source	Last verified
ACA price	$145.20 close on July 31, 2026	Yahoo Finance Chart API and stockanalysis.com	August 3, 2026
CRH cash offer	$150.00 per share, all cash	CRH press release, June 22, 2026	August 3, 2026
Deal value	About $8.5 billion including debt	Reuters and WSJ deal reports, June 22, 2026	August 3, 2026
Market capitalization	$7.13 billion, verified as $145.20 x 49,110,000 shares	financial_rigor.py market cap verification	August 3, 2026
TTM revenue	$2.82 billion	Google Finance quarterly revenue data (last 4 quarters)	August 3, 2026
TTM net income	$222.6 million	Google Finance quarterly net income data	August 3, 2026
TTM EPS	$4.53	Google Finance summary data and stockanalysis.com	August 3, 2026
TTM EBITDA	About $524 million	Calculated from Google Finance quarterly EBITDA data	August 3, 2026
FY2025 revenue	$2.88 billion, up 12.2%	stockanalysis.com financials (S&P Global data)	August 3, 2026
FY2025 net income	$208.4 million, up 122.7%	stockanalysis.com financials (S&P Global data)	August 3, 2026
Q1 2026 revenue	$571.7 million	Google Finance Q1 2026 data	August 3, 2026
Q1 2026 net income	$37.8 million (EPS $0.81)	Google Finance Q1 2026 data	August 3, 2026
Q2 2026 earnings date	August 5, 2026	stockanalysis.com and Google Finance earnings calendar	August 3, 2026
Shares outstanding	49.11 million	stockanalysis.com	August 3, 2026
Valuation math	32.05x TTM PE from financial_rigor.py verification	financial_rigor.py valuation verification	August 3, 2026

Frequently Asked Questions

Read the CAT AI stock analysis View the CMI AI stock forecast Explore AI Stock Picker Generate an AI trading strategy

This ACA AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of August 3, 2026, including the pending CRH acquisition, and can be wrong. The transaction is subject to approvals that may not be obtained.